- Release Date: 08/04/24 08:57
- Summary: SYNThesis BioVentures MoU for cellular immunotherapies
- Price Sensitive: Yes
- Download Document 211.2KB
- Forums
- ASX - By Stock
- 1AD
- Ann: SYNThesis BioVentures MoU for cellular immunotherapies
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.33M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.5¢ | $8.674K | 339.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 764357 | 2.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 49955 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 764357 | 0.024 |
2 | 320000 | 0.023 |
4 | 355000 | 0.022 |
3 | 1197615 | 0.021 |
6 | 1101472 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 49955 | 1 |
0.027 | 17121 | 1 |
0.028 | 300000 | 1 |
0.029 | 92629 | 3 |
0.030 | 810875 | 4 |
Last trade - 15.53pm 30/05/2024 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online